Latest News
July 10, 2017
U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibb’s Application for Sprycel (dasatinib) in Children with Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia
July 6, 2017
Bristol-Myers Squibb’s ORENCIA (abatacept) Receives FDA Approval for Treatment of Active Psoriatic Arthritis (PsA) in Adults
July 5, 2017
Phase 3 Study Evaluating the Safety and Efficacy of Adjuvant Opdivo in Resected High-Risk Melanoma Patients Meets Primary Endpoint
Latest Events
Event year list
2017
2016
2015
2014
2013
2012
July 27, 2017
10:30 AM ET
2017 Second Quarter Results Conference Call
Webcast
(opens in new window)
June 14, 2017
10:00 AM PT
Goldman Sachs 38th Annual Global Healthcare Conference
June 4, 2017
06:30 PM CT
Bristol-Myers Squibb Investor Event: ASCO 2017
Webcast
(opens in new window)
View this presentation
(opens in new window)
(
PDF
2.37 MB
)